ApprovalTrail

Approval · Notice of Compliance 2930 · 1998

FENTANYL CITRATE: Notice of Compliance 2930

Issued January 23, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2930
Date
January 23, 1998
Company
Technilab Pharma Inc.Mirabel, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Opioid analgesic adjunct fto anesthesia
Canadian reference product
SUBLIMAZE INJ.

Products in this notice

BrandDINStatus today
FENTANYL CITRATE02237197—

Medicinal ingredients